UK receiving check
Identify the receiving licensed importer, product authorisation and whether the destination is Great Britain or Northern Ireland.
Sourcing a medicine from India for the UK? Start with the active ingredient, strength, dosage form and pack size. Tell us whether the recipient is an individual or a licensed organisation, and whether the destination is Great Britain or Northern Ireland. Product information and available documents can then be discussed against the intended receiving route.
Identify the receiving licensed importer, product authorisation and whether the destination is Great Britain or Northern Ireland.
Branded and generic medicines across relevant therapeutic categories, with product information and quotation support.
Invoice, packing information, manufacturer details, COA or COO support where applicable and available.
Start with your buyer type and the exact medicine. The relevant receiving route must be checked for each request.
Ask your UK prescriber or pharmacy to confirm the appropriate supply route for your medicine. A prescription alone does not establish that an overseas seller can supply or import it.
Identify the receiving licensed importer, product authorisation and whether the destination is Great Britain or Northern Ireland. Licensed and unlicensed medicines follow different MHRA import routes.
Include the product, strength, dosage form, pack size, quantity, destination and intended use. Available product documents and handling requirements can then be discussed.
Official destination guidance
UK procurement teams should identify the intended licensed importer, product authorisation status and whether the destination is Great Britain or Northern Ireland. MHRA distinguishes licensed-medicine imports from the separate unlicensed-medicine route. Share the applicable importer licence and product details before requesting shipment coordination; a supplier quotation does not replace those permissions. Official import guidance.
Share the receiving organisation or buyer, postal destination and intended use. Confirm the applicable receiving route before requesting shipment coordination.
Buyers can also review support pages for bulk enquiries, hospital supply, cold-chain medicines, specialty sourcing and pharmaceutical documentation.
Buyers can browse category-specific enquiry pages for relevant products, strengths and pack sizes.
Individuals, importers, pharmacies, clinics, hospitals and procurement teams may send product enquiries for review. Acceptance of an enquiry does not confirm medicine availability, permission to supply or import eligibility.
Ask your UK prescriber or pharmacy to confirm the appropriate supply route for your medicine. A prescription alone does not establish that an overseas seller can supply or import it.
Identify the receiving licensed importer, product authorisation and whether the destination is Great Britain or Northern Ireland. Licensed and unlicensed medicines follow different MHRA import routes.
State the medicine or active ingredient, strength, dosage form, pack size, quantity, destination and buyer type. The team can then discuss product information and available documentation. Do not send medical histories or identity documents in an initial general enquiry.
No. Product availability and price do not establish permission to supply or import. The applicable receiving route and product requirements must be confirmed before shipment is arranged.
An unlicensed medicine requires a separate receiving-route review. MHRA guidance covers the relevant importer licence and advance notification process. The receiving importer should confirm the applicable requirements for the product and source country before shipment is arranged.
No. MHRA describes specials as a route for an individual clinical need that available licensed medicines cannot meet. The prescriber determines that need. The receiving importer must check the relevant licence and MHRA notification requirements; a sourcing enquiry or lower overseas price does not establish eligibility.